Collectively, our results demonstrate that butorphanol tartrate displays beneficial capacities on Hcy-induced BBB disruption by upregulating the expressions of KLF5 and Claudin-5, suggesting a novel pharmacological function of butorphanol tartrate on brain cardiovascular diseases such as stroke. Here, KLF5 is linked to stroke disorder.